Wedbush Trims Biogen (NASDAQ:BIIB) Target Price to $213.00
Biogen (NASDAQ:BIIB – Free Report) had its price target decreased by Wedbush from $245.00 to $213.00 in a report released on Wednesday morning, Benzinga reports. Wedbush currently has a neutral rating on the biotechnology company’s stock. Wedbush also issued estimates for Biogen’s Q1 2024 earnings at $3.25 EPS, Q3 2024 earnings at $4.13 EPS, Q4 […]
More Stories
Lee Dong Wook Has Joined Netflix’s Upcoming Series, The Facade of Love
Netflix’s upcoming series, The Facade of Love, is a romantic Korean series that is based on a one-night accident that...
Little Brother, John Cena’s Latest Movie Release Date, Cast, and Trailer
Netflix’s recent and upcoming film, Little Brother, is grabbing the attention of both comedy movie lovers and WWE fans because...
Judge Rules Virginia Redistricting Referendum Unconstitutional
By Jill McLaughlin A Virginia judge ruled on April 22 that the state’s redistricting referendum approved by voters a day earlier...
US Land Prices Climb 77 Percent Since Pandemic as Inventory Remains Low: Report
By Mary Prenon Land prices across the United States over the last decade seem to be following the path of...
German Airline Lufthansa to Cut 20,000 Flights to Save Jet Fuel
By Victoria Friedman German airline Lufthansa announced on April 21 that 20,000 short-haul flights would be canceled this summer due...
Duffy Seeking $10 Billion From Congress to Revamp Air Traffic Control System
By Aldgra Fredly U.S. Transportation Secretary Sean Duffy said on April 21 the department requires $10 billion in additional funding...